Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
2,886
Funds Holding Change
+116
Funds Holding Growth
+4%
Value
$952B
Holding in Top 10
1,334
Top 10 Change
+78
Top 10 Growth
+6%
Value Growth
+7%
New
235
Increased
1,306
Reduced
1,197
Closed
78
Capital Inflow
$28.8B
Capital Outflow
$31.2B
Net Capital Flow
-$2.35B
Capital Flow Change
-$7.25B
Calls
$10.9B
Puts
$13B
Net Calls
-$2.14B
Put/Call Ratio
1.2